Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Short term Debt: 2024

Historic Short term Debt for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $2.6 million.

  • Kura Oncology's Short term Debt rose 152.89% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 152.89%. This contributed to the annual value of $2.6 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Short term Debt of $2.6 million as of FY2024.
  • Kura Oncology's 5-year Short term Debt high stood at $2.6 million for FY2024, and its period low was $2.6 million during FY2024.
  • In the last 1 years, Kura Oncology's Short term Debt had a median value of $2.6 million in 2024 and averaged $2.6 million.